Cantor Equity Partners III, Inc.

# Signal Note: Driehaus Initiates CAEP Position Driehaus Capital's $1.5M entry into Cantor Equity Partners III suggests conviction in the fund's portfolio companies, though CAEP's specific holdings and near-term catalysts require clarification given its structure as a closed-end fund rather than an operating biotech. The position size is modest relative to Driehaus's AUM, indicating opportunistic allocation rather than conviction-level bet. Monitor upcoming CAEP portfolio disclosures and clinical readouts from its underlying investments to assess whether this reflects emerging data or valuation opportunity.